Normunity raises funds to develop immuno-oncology therapies

Normunity has raised $65m in Series A financing round for expanding the frontier of precision immuno-oncology with immune normaliser therapies.

Related Keywords

Lieping Chen ,Rachel Humphrey ,Yale School Of Medicine ,Osage University Partners ,Canaan Ventures ,Taiho Ventures ,Yale School ,